Pharmacovigilance for Your Clinical Trials
At QPS, we have established robust systems to identify, record, report, and analyze safety data throughout a clinical trial. These systems are designed to ensure that any potential safety signals are quickly detected and thoroughly evaluated, allowing for rapid decision-making and intervention when necessary. Our proactive approach includes continuous monitoring and assessment, helping to mitigate risks and protect participant safety while maintaining compliance with regulatory requirements. By leveraging advanced tools and methodologies, we ensure that safety management is a seamless, integral part of the clinical trial process.
Our safety reporting and pharmacovigilance services include:
- Creation of safety management plans.
- Development of your safety database.
- Safety reporting both electronically and on paper.
- Maintenance of safety databases for your studies.
- Medical Monitoring
- Complete safety management of your clinical study including medical review.
Links to Relevant Documents
- Efficiently Performing Two Global Approval Studies in Prostate Cancer Patients
- Phase II-IV Clinical Overview
- Phase II-IV Clinical Services & Locations
- Early Phase Clinical Overview
- Expedited Study Delivery – Logistics
- Expedited Study Delivery – Pharmacy
- Studying Sedatives in Phase I Studies
- Pharmacokinetic Studies in Patients
- Corporate Overview Clinical Sites
Testimonials
Thank you for making all the changes within our requested timeline. The updated dataset looks great! We greatly appreciate your efforts in helping us to meet our study timelines.
JOSHUA H.
Molly and I both really appreciate the extra time and effort the QPS team made in getting this document turned around so quickly. Job well done!
LISA L.
Previous
Next